Does midlife obesity really lower dementia risk?

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 7, 2015, Pages 498-

  Kivimäki, Mika ^a   Singh Manoux, Archana ^a,b   Shipley, Martin J ^a   Elbaz, Alexis ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BODY MASS; DEMENTIA; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNDERWEIGHT; BODY WEIGHT; COMPLICATION; FEMALE;

BODY MASS INDEX; DEMENTIA; FEMALE; HUMANS; MALE; OBESITY; THINNESS;

EID: 84934280074     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00216-8     Document Type: Letter

References (5)

1. Daviglus ML, Bell CC, Berrettini W, et al. National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline. Ann Intern Med 2010, 153:176-181.
2. Qizilbash N, Gregson J, Johnson ME, et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol 2015, 3:431-436.
3. Reid DD, Hamilton PJS, McCartney P, et al. Cardiorespiratory disease and diabetes among middle-aged male civil servants. Lancet 1974, 303:469-473.
4. Debette S, Wolf C, Lambert JC, et al. Abdominal obesity and lower gray matter volume: a Mendelian randomization study. Neurobiol Aging 2014, 35:378-386.
5. Keller L, Xu W, Wang HX, Winblad B, Fratiglioni L, Graff C The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis 2011, 23:461-519.